Completed NA INTERVENTIONAL 1-arm NCT03981679

Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay. (DEPLR)

Prospective, Non-randomized, Open-label and Multi-center Study With the Establishment of a Clinical-biological Database.

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle

Conditions Colorectal Cancer

Interventions Biological collection

Updated 5 times since 2019 Last updated: Aug 3, 2020 Started: Jun 5, 2018 Primary completion: Jan 17, 2020 Completion: Jan 17, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Colorectal Cancer, this trial is completed. The trial is conducted by Institut du Cancer de Montpellier - Val d'Aurelle and has accumulated 5 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jul 2019 — Sep 2020 [monthly]

Recruiting NA

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut du Cancer de Montpellier - Val d'Aurelle

Data source: Institut du Cancer de Montpellier - Val d'Aurelle

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montpellier, France